In B. fragilis 638R, bfp4 was found on a 55.9 Kb insertion, called Bfgi2 in this study. Annotation of this insertion revealed an architecture similar

to the CTnERL-type conjugative transposons (CTn) [30] (Fig. 5, panel A and Table 5). Although the expected integrase, excisionase and transfer regions were present in Bfgi1, mobility of this insertion could not be established for broth grown cultures treated with mitomycin C, tetracycline, or UV treatment (data not shown). These treatments are commonly used to initiate excision of CTn elements [31, 32]. Bfgi1 showed homology to a region in Porphyromonas gingivalis ATCC 33277 which has previously been characterized as a CTn [33]. However, this region of ATCC 33277 did not encode a C10 protease. Table 5 Annotation of genes in the B. fragilis 638R Bfgi1 insertion. ORF Protein Length Putative function % Id/Sima Organismb Accession no.c 1 411 Integrase protein 59/74 (411) MM-102 in vivo B. fragilis {Selleck Anti-cancer Compound Library|Selleck Anticancer Compound Library|Selleck Anti-cancer Compound Library|Selleck Anticancer Compound Library|Selleckchem Anti-cancer Compound Library|Selleckchem Anticancer Compound Library|Selleckchem Anti-cancer Compound Library|Selleckchem Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|buy Anti-cancer Compound Library|Anti-cancer Compound Library ic50|Anti-cancer Compound Library price|Anti-cancer Compound Library cost|Anti-cancer Compound Library solubility dmso|Anti-cancer Compound Library purchase|Anti-cancer Compound Library manufacturer|Anti-cancer Compound Library research buy|Anti-cancer Compound Library order|Anti-cancer Compound Library mouse|Anti-cancer Compound Library chemical structure|Anti-cancer Compound Library mw|Anti-cancer Compound Library molecular weight|Anti-cancer Compound Library datasheet|Anti-cancer Compound Library supplier|Anti-cancer Compound Library in vitro|Anti-cancer Compound Library cell line|Anti-cancer Compound Library concentration|Anti-cancer Compound Library nmr|Anti-cancer Compound Library in vivo|Anti-cancer Compound Library clinical trial|Anti-cancer Compound Library cell assay|Anti-cancer Compound Library screening|Anti-cancer Compound Library high throughput|buy Anticancer Compound Library|Anticancer Compound Library ic50|Anticancer Compound Library price|Anticancer Compound Library cost|Anticancer Compound Library solubility dmso|Anticancer Compound Library purchase|Anticancer Compound Library manufacturer|Anticancer Compound Library research buy|Anticancer Compound Library order|Anticancer Compound Library chemical structure|Anticancer Compound Library datasheet|Anticancer Compound Library supplier|Anticancer Compound Library in vitro|Anticancer Compound Library cell line|Anticancer Compound Library concentration|Anticancer Compound Library clinical trial|Anticancer Compound Library cell assay|Anticancer Compound Library screening|Anticancer Compound Library high throughput|Anti-cancer Compound high throughput screening| YCH46 AAS83518.1 2 119 Hypothetical protein 42/64 (114) B. thetaiotaomicron

AA077037.1 3 162 Ctn042 37/59 (112) B. fragilis YCH46 AAS83514.1 4 1828 DNA Methylase (BmhA) 57/71 (1339) B. fragilis YCH46 AAS83508.1 5 143 Hypothetical protein 41/56 (121) B. thetaiotaomicron AA077432.1 6 709 Excisionase 57/72 (704) B. fragilis YCH46 AAS83511.1 7 464 Hypothetical protein 41/57 (482) B. thetaiotaomicron AA075210.1 8 260 TetR/AcrR family 32/58 (204) B. thetaiotaomicron AA075614.1 9 161 Hypothetical protein 48/71 (108) P. gingivalis W83 AA075614.1 10 780 Putative TonB OM Receptor 63/78 (780) B. fragilis YCH46 BAD47377.1 11 412 Hypothetical protein 56/73 (398) B. fragilis YCH46 CAH06331.1 12 187 Putative Ni-Co-Cd resistance Racecadotril protein 29/42 (110) Syntrophus aciditrophicus SB ABC78121.1 13 604 ABC Transporter 41/61 (570) B. thetaiotaomicron AA075616.1 14 593 ABC Transporter 43/63 (591) B. thetaiotaomicron this website AA075615.1 15 172 RteC 56/76 (80) B. thetaiotaomicron AAA22922.1 16 129 Peptidase S51 44/59 (100) Listeria monocytogenes AAT03167.1 17 114 Hypothetical protein 69/79 (73) P. gingivalis W83 AAQ66123.1 18 138 Hypothetical protein

34/53 (135) B. thetaiotaomicron AA077558.1 19 431 C10 protease 26/43 (454) B. thetaiotaomicron AA077558.1 20 112 Hypothetical protein 27/72 (80) Polaribacter irgensii A4BZ61 21 512 ECF type σ-factor 31/50 (502) B. thetaiotaomicron AA077884.1 22 148 Hypothetical protein 43/58 (46) Campylobacter upsaliensis EAL52724.1 23 671 MobC 51/91 (660) B. fragilis YCH46 AAS83500.1 24 408 MobB 53/71 (348) B. fragilis YCH46 AAS83499.1 25 137 MobA 46/66 (136) B. fragilis YCH46 AAS83498.1 26 260 TraA 53/71 (246) B. fragilis YCH46 AAG17826.1 27 142 TraB 34/51 (133) B. fragilis YCH46 BAD48110.1 28 135 TraC 34/55 (63) B. fragilis YCH46 AAS83495.1 29 271 TraA 37/53 (251) B. fragilis YCH46 BAD49765.1 30 196 TraD 26/37 (182) B. thetaiotaomicron AA077408.1 31 123 TraE 73/79 (78) B. fragilis YCH46 BAD48110.1 32 126 TraF 56/66 (87) B.